Rimiterol hydrobromide

This classification denotes a beta-adrenergic agonist with the molecular formula C12H17NO3.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I29DRR8S3R, chemically known as 1,2-benzenediol, 4-(hydroxy-2-piperidinylmethyl)-, hydrobromide, (r*,s*)- (9ci) but more generally known as rimiterol hydrobromide, which bears US NIH Compound Identifier 71409. European Medicines Agency schedules Rimiterol hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04251MIG. Most nations, for tariff and trade purposes, schedule rimiterol hydrobromide under HS 29333999 and SITC 51574. As of Q4 2014, RIMITEROL HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Rimiterol hydrobromide bears US NLM identifiers UMLS ID C0700493 and NCI Concept Code C81646. SMILES: C1CC(C(CC1[C@H]([C@@H]2CCCCN2)O)O)O.BR.